20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Veracyte Inc (VCYT) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in South San Francisco, United States with about 755 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, VCYT reported $517M in revenue and $66M in net income.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
Interactive charts & full statements → Open the VCYT valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $562M | $517M | $446M | $361M | $297M | $220M | $117M | $120M | $92M | $72M | $65M | $50M | $38M | $22M | $12M | $3M |
| Gross Profit | $405M | $360M | $298M | $248M | $195M | $145M | $76M | $84M | $59M | $44M | $40M | $28M | $22M | $9M | $4M | $0M |
| Gross Margin % | 72.1% | 69.6% | 66.9% | 68.7% | 65.7% | 66.1% | 64.7% | 69.7% | 64.0% | 60.8% | 60.9% | 56.6% | 56.5% | 42.4% | 34.8% | -10.6% |
| Operating Income (EBIT) | $96M | $74M | $16M | ($86M) | ($41M) | ($82M) | ($35M) | ($15M) | ($22M) | ($27M) | ($29M) | ($33M) | ($29M) | ($23M) | ($19M) | ($15M) |
| Operating Margin % | 17.0% | 14.3% | 3.6% | -23.8% | -13.9% | -37.3% | -30.1% | -12.6% | -24.2% | -36.9% | -44.2% | -67.6% | -75.9% | -105.9% | -162.8% | -577.2% |
| Net Income | $114M | $66M | $24M | ($74M) | ($37M) | ($76M) | ($35M) | ($13M) | ($23M) | ($31M) | ($31M) | ($34M) | ($29M) | ($26M) | ($19M) | ($14M) |
| Net Margin % | 20.4% | 12.8% | 5.4% | -20.6% | -12.3% | -34.4% | -29.7% | -10.5% | -25.0% | -43.1% | -48.2% | -68.1% | -76.9% | -116.9% | -160.4% | -546.1% |
| EBITDA | $130M | $90M | $49M | ($49M) | ($7M) | ($60M) | ($27M) | ($8M) | ($17M) | ($24M) | ($25M) | ($33M) | ($29M) | ($24M) | ($18M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $150M | $139M | $141M | $132M | $130M | $114M | $119M | $116M |
| Gross Profit | $109M | $101M | $105M | $91M | $90M | $80M | $79M | $79M |
| Gross Margin % | 72.2% | 72.3% | 74.4% | 69.2% | 69.0% | 69.5% | 66.4% | 68.2% |
| Operating Income (EBIT) | $23M | $24M | $26M | $23M | ($5M) | $3M | $4M | $12M |
| Operating Margin % | 15.3% | 17.2% | 18.4% | 17.4% | -4.0% | 2.5% | 3.5% | 10.4% |
| Net Income | $25M | $29M | $41M | $19M | ($1M) | $7M | $5M | $15M |
| Net Margin % | 17.0% | 20.6% | 29.3% | 14.5% | -0.8% | 6.2% | 4.3% | 13.1% |
| EBITDA | $24M | $35M | $46M | $24M | $7M | $7M | $10M | $23M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $178M | $136M | $75M | $44M | $8M | ($32M) | ($10M) | ($3M) | ($14M) | ($24M) | ($28M) | ($27M) | ($28M) | ($19M) | ($7M) | ($14M) |
| Capital Expenditures (CapEx) | $13M | $10M | $11M | $10M | $9M | $5M | $3M | $3M | $2M | $2M | $4M | $6M | $2M | $1M | $1M | $0M |
| Free Cash Flow (FCF) | $165M | $127M | $64M | $34M | ($1M) | ($37M) | ($13M) | ($6M) | ($15M) | ($26M) | ($32M) | ($33M) | ($30M) | ($20M) | ($9M) | ($14M) |
| FCF Margin % | 29.4% | 24.5% | 14.3% | 9.5% | -0.3% | -16.9% | -10.7% | -5.0% | -16.7% | -35.7% | -49.5% | -66.9% | -77.6% | -93.6% | -74.2% | -521.7% |
| Dividends Paid | — | — | — | — | $3M | — | $4M | $1M | — | $0M | $0M | $0M | $9M | $0M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $46M | $35M | $53M | $45M | $34M | $5M | $25M | $30M |
| Capital Expenditures (CapEx) | $3M | $3M | $4M | $3M | $1M | $2M | $4M | $2M |
| Free Cash Flow (FCF) | $43M | $32M | $48M | $42M | $32M | $4M | $20M | $28M |
| FCF Margin % | 28.6% | 23.2% | 34.3% | 31.8% | 24.8% | 3.1% | 17.2% | 23.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VCYT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms